Laxapana PLC - Income Statement (TTM)

Laxapana PLC
LK ˙ COSE
Income Statement (TTM)

Laxapana PLC Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 671 697 753 785 784 809 868 921 1,026 999 916 886 788 818 1,000 1,482 2,063 2,809 3,358 3,587
Change (%) 3.86 8.06 4.22 -0.11 3.14 7.38 6.04 11.45 -2.68 -8.33 -3.19 -11.07 3.77 22.19 48.22 39.22 36.21 19.51 6.84
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 478 484 524 549 559 589 638 637 679 664 525 543 503 505 739 1,098 1,548 2,106 2,512 2,655
Change (%) 1.17 8.32 4.84 1.77 5.33 8.37 -0.08 6.51 -2.25 -20.87 3.32 -7.29 0.40 46.30 48.56 41.01 36.04 19.29 5.69
% of Revenue 71.21 69.37 69.54 69.96 71.28 72.79 73.46 69.22 66.16 66.44 57.36 61.21 63.81 61.74 73.93 74.10 75.05 74.96 74.82 74.01
Gross Operating Profit 193 214 229 236 225 220 230 283 347 335 390 344 285 313 261 384 515 704 846 932
Change (%) 10.50 7.45 2.80 -4.51 -2.28 4.71 22.98 22.57 -3.51 16.49 -11.94 -17.03 9.70 -16.72 47.26 34.10 36.71 20.18 10.28
% of Revenue 28.79 30.63 30.46 30.04 28.72 27.21 26.54 30.78 33.84 33.56 42.64 38.79 36.19 38.26 26.07 25.90 24.95 25.04 25.18 25.99
SG&A 145 146 158 172 168 173 138 145 165 164 233 240 225 259 345 442 559 653 632 642
Change (%) 0.78 8.18 9.15 -2.41 2.57 -20.25 5.15 13.90 -0.33 41.74 3.05 -6.04 14.86 33.29 27.96 26.47 16.99 -3.21 1.58
% of Revenue 21.58 20.94 20.97 21.96 21.46 21.34 15.85 15.71 16.06 16.45 25.43 27.07 28.60 31.66 34.53 29.81 27.08 23.26 18.84 17.91
R&D
Change (%)
% of Revenue
OpEx 590 589 633 670 666 695 702 697 757 747 662 694 632 656 956 1,404 1,975 2,636 3,055 3,220
Change (%) -0.17 7.49 5.81 -0.57 4.28 1.09 -0.77 8.57 -1.33 -11.33 4.77 -8.85 3.69 45.85 46.89 40.62 33.47 15.91 5.39
% of Revenue 87.93 84.52 84.08 85.37 84.98 85.91 80.88 75.69 73.73 74.75 72.30 78.25 80.20 80.14 95.65 94.79 95.74 93.82 90.99 89.75
Operating Income 81 108 120 115 118 114 166 224 270 252 254 193 156 162 43 77 88 174 302 368
Change (%) 33.22 11.18 -4.22 2.53 -3.28 45.71 34.84 20.44 -6.44 0.54 -23.97 -19.04 4.10 -73.25 77.47 13.80 97.70 74.29 21.54
% of Revenue 12.07 15.48 15.92 14.63 15.02 14.09 19.12 24.31 26.27 25.25 27.70 21.75 19.80 19.86 4.35 5.21 4.26 6.18 9.01 10.25
Interest Expense -7 -5 -5 -3 -17 -19 -25 -34 -15 -23 -22 -16 -31 -29 -37 -54 -61 -52 -73 -72
Change (%) -35.13 9.27 -44.26 514.95 13.54 27.48 37.79 -55.18 49.52 -3.80 -26.02 90.21 -5.03 26.93 44.31 12.86 -13.87 38.39 -0.93
% of Revenue -1.05 -0.66 -0.66 -0.36 -2.19 -2.41 -2.86 -3.71 -1.49 -2.29 -2.41 -1.84 -3.94 -3.60 -3.74 -3.64 -2.95 -1.87 -2.16 -2.01
Net Income 60 80 85 79 69 65 100 138 184 162 134 90 53 61 256 268 278 333 167 211
Change (%) 34.28 5.86 -6.67 -12.65 -5.69 53.72 38.09 33.12 -11.84 -17.42 -33.02 -40.81 13.90 322.34 4.92 3.82 19.58 -49.75 26.42
% of Revenue 8.88 11.48 11.25 10.07 8.81 8.05 11.53 15.01 17.93 16.24 14.63 10.13 6.74 7.40 25.57 18.10 13.50 11.85 4.98 5.89

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista